Actively Recruiting
Registry Study for Pregnant Women with Autoimmune and Rheumatic Diseases Tracking Pregnancy and Baby Health Outcomes
Led by Duke University · Updated on 2026-01-08
1000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are enrolling pregnant women or those planning pregnancy within 6 months who have autoimmune and rheumatologic diseases. The study aims to better understand risk factors related to increased inflammation before and during pregnancy that may affect the health of both mothers and their babies. This registry study collects data over several years to help improve outcomes for women with rheumatic diseases. Participants will remain under the care of their own rheumatologist and obstetrician throughout pregnancy. This observational study does not involve extra treatments, medications, lab tests, or procedures outside standard care. Data from routine office visits during pregnancy and for up to 12 months after delivery will be collected and analyzed periodically. Women enrolled will provide health information through their regular medical visits without added risks. Researchers will track outcomes related to pregnancy risks using tools like the MADRA-DAP questionnaire over up to 10 years. The study is ongoing with periodic reviews to better define factors influencing pregnancy health in women with autoimmune diseases.
CONDITIONS
Brief Title
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Research Team
L
Laura Neil
E
Edna Scarlett
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here